妊娠与非妊娠现役军人Tdap疫苗免疫原性比较
该观察性队列研究纳入240名妊娠期接种Tdap的现役军人与240名非妊娠现役军人按年龄、采血间隔和同日接种其他疫苗1:1匹配,比较接种后9-15个月抗百日咳毒素IgG水平。结果显示妊娠组接种前后抗体几何平均浓度均较高,但调整接种前水平后两组长期应答无显著差异,且距前次Tdap加强剂时间修饰该关联。
要点
- 妊娠期接种Tdap后9-15个月抗PT IgG应答与非妊娠接种相似。
- 妊娠组接种前后抗PT IgG几何平均浓度均高于非妊娠组。
- 距前次Tdap加强剂不足2年者中,妊娠与抗体水平关联有统计学差异。
核心结论
- 妊娠期接种Tdap产生的长期抗百日咳毒素IgG应答与非妊娠期接种相似,支持现行推荐接种程序。
研究设计与样本
- 观察性队列研究,纳入240名妊娠期接种Tdap的现役军人与240名非妊娠现役军人按年龄、疫苗至采血间隔及同日接种其他疫苗1:1匹配(2011-2016)。
- 血清样本取自国防部血清库,为接种前0-6周和接种后9-15个月,采用几何平均浓度评估抗PT IgG,多变量线性回归分析关联。
临床怎么用
- 现行妊娠期Tdap接种推荐可维持,无需因长期免疫应答差异调整接种策略。
- 评估妊娠期Tdap免疫效果时应考虑接种前抗体水平和距前次加强剂时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination in pregnancy is recommended to provide passive immunity to newborns. Few studies have assessed how pregnancy modifies vaccinated individuals' immune response to Tdap vaccination, with most focused on short-term responses (i.e., within 1 month). Here, we assessed anti-pertussis toxin (PT) immunoglobulin G (IgG) levels 9-15 months following Tdap vaccination in pregnant and non-pregnant active duty service members (ADSMs). METHODS: This observational cohort study included 240 ADSMs pregnant at Tdap vaccination, 1:1 matched with 240 non-pregnant ADSMs on age, time between vaccine and serum collection, and receipt of other same-day vaccines (2011-2016). Serum samples (0-6 weeks before and 9-15 months after vaccination) were obtained from the Department of Defense Serum Repository. Anti-PT IgG levels were assessed using geometric mean concentrations (GMCs), and associations between pregnancy status at vaccination and anti-PT IgG levels were estimated through multivariable linear regression models. RESULTS: Pregnant vs. non-pregnant ADSMs had higher anti-PT IgG GMCs in both pre- (9.01 vs. 5.81, P < .01) and post-vaccine (27.71 vs. 22.33, P = .02) serums. Post-vaccine multivariable models adjusting for pre-vaccine levels were not significantly different between pregnant vs. non-pregnant ADSMs (b = -0.05, P = .42). Associations were modified by time since prior Tdap booster, and statistically different for pregnant individuals who received a booster <2 years prior (b = -0.22, P = .02). CONCLUSION: Tdap vaccination in pregnancy yielded a similar long-term anti-PT IgG response to vaccination outside of pregnancy; findings substantiate the current recommended vaccine schedule.
引用
- Khodr ZG, Hall C, Bukowinski AT, et al. Comparison of Tdap vaccine immunogenicity between pregnant and non-pregnant active duty service members. Vaccine. 2026. PMID: 42066578. doi:10.1016/j.vaccine.2026.128627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。